文献速递腹部USMR

使用超声衰减成像无创评估代谢功能障碍相关脂肪性肝病患者的肝脏脂肪变

Noninvasive Assessment of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients by Using Ultrasound Attenuation Imaging.
PubMed 文献 · J Ultrasound Med · 2025-12-18

本研究以MRI-PDFF为参考标准,评估超声衰减分析(USAT)在145例MASLD患者中诊断肝脂肪变的性能。USAT与MRI-PDFF相关系数为0.805,预测脂肪变≥S1、≥S2、=S3的AUC分别为0.90、0.92、0.92,诊断性能优于视觉分级和临床预测模型。

要点

  • USAT预测脂肪变≥S1、≥S2、=S3的AUC分别为0.90、0.92、0.92。
  • 对应截断值分别为0.61、0.71、0.82 dB/cm/MHz。
  • USAT诊断性能优于视觉肝脂肪变分级、HSI和FSI。

核心结论

  • USAT是一种有前景的定量工具,可用于MASLD患者肝脂肪变的定量评估,与MRI-PDFF相关性较强。

研究设计与样本

  • 诊断性能研究,共纳入145例参与者,同日行USAT和MRI-PDFF检查,以MRI-PDFF阈值为参考标准分级肝脂肪变。

诊断标准与关键数值

  • USAT预测脂肪变≥S1的AUC为0.90,截断值0.61 dB/cm/MHz;预测≥S2的AUC为0.92,截断值0.71 dB/cm/MHz;预测=S3的AUC为0.92,截断值0.82 dB/cm/MHz。

临床应用与阅片要点

  • USAT与MRI-PDFF的相关系数为0.805(p < .050)。
  • 甘油三酯和脂肪变分级是USAT的显著决定因素。
  • USAT诊断性能在统计学上优于视觉肝脂肪变分级、HSI和FSI。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the diagnostic performance of ultrasound attenuation analysis (USAT) in evaluating hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), with magnetic resonance imaging proton density fat fraction (MRI-PDFF) as the reference.

METHODS: Participants were recruited. Each participant underwent both USAT and MRI-PDFF examinations on the same day. We employed MRI-PDFF thresholds to classify the stages of hepatic steatosis. Univariable and multivariable linear regression analyses were conducted to identify significant factors influencing USAT. Receiver operating characteristic (ROC) curve analysis was utilized to evaluate the diagnostic performance of USAT in predicting the grade of liver steatosis and compared with visual hepatic steatosis grade (VHSG) and clinical prediction models.

RESULTS: A total of 145 patients took part in this study. The correlation coefficient between USAT and MRI-PDFF was 0.805 (p < .050). USAT varied significantly across different hepatic steatosis grade. Triglyceride (TG) and steatosis grade were significant determinant factors for USAT. The areas under the ROC curve of USAT for predicting steatosis ≥ S1, ≥ S2, and =S3 were 0.90 (cut-off value of 0.61 dB/cm/MHz), 0.92 (cut-off value of 0.71 dB/cm/MHz), and 0.92 (cut-off value of 0.82 dB/cm/MHz), respectively. The diagnostic performance of USAT was statistically better than that of VHSG, Hepatic steatosis index (HSI), and Framingham steatosis index (FSI).

CONCLUSION: USAT is a promising quantitative tool for the quantitative assessment of hepatic steatosis in patients with MASLD, demonstrating a stronger correlation with MRI-PDFF.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Wang K, Liu Q, Wang J, et al. Noninvasive Assessment of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients by Using Ultrasound Attenuation Imaging. J Ultrasound Med. 2025. PMID: 41410300. doi:10.1002/jum.70156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。